Related Experiment Video
Updated: Aug 30, 2025
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
Treatment outcome, cognitive function, and psychopathology in methamphetamine users compared to other substance users
Nina Behle1, Felicia Kamp1, Lisa Proebstl1
1Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Munich 80336, Germany.
World Journal of Psychiatry
|September 2, 2022
Summary
Methamphetamine users show differences in cognitive function and psychopathology compared to other substance users. However, current inpatient treatments appear equally effective for both groups, indicating successful methamphetamine dependence management.
Area of Science:
- Addiction medicine
- Neuroscience
- Psychiatry
Background:
- Increasing methamphetamine use necessitates effective treatment options.
- Limited evidence exists on the efficacy of current treatments for methamphetamine dependence.
- Investigating differences between methamphetamine and other substance users is crucial for treatment adaptation.
Purpose of the Study:
- To compare cognitive functioning and psychopathology between methamphetamine and other substance users.
- To explore correlations between these differences and treatment outcomes.
- To assess the effectiveness of existing treatments for methamphetamine dependence.
Main Methods:
- An observational, longitudinal study of 110 inpatient subjects (55 methamphetamine users, 55 other substance users).
- Assessment at baseline and 6 months included cognitive tests, craving scales, and psychopathology inventories.
- Statistical analysis involved chi-squared tests, t-tests, and ANOVAs.
Main Results:
- No significant difference in dropout rates between groups.
- Methamphetamine users had lower IQ, education, and conscientiousness, with slower working speed and accuracy.
- Both groups showed reduced craving and depressive symptoms, with improved cognitive speed and accuracy post-treatment.
Conclusions:
- Methamphetamine users exhibit distinct cognitive and psychopathological profiles compared to other substance users.
- Despite these differences, current inpatient treatment strategies are effective for methamphetamine dependence.
- Existing treatment models can be successfully applied to manage methamphetamine addiction.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
320
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
320
01:24Substance Use Disorders Affecting Sleep
212
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
212
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
196
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
196
01:30Attention-Deficit/Hyperactivity Disorder
170
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
170
01:15Drug Abuse and Addiction: Pharmacological Phenomena
634
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
634
01:26Psychosis: Goals of Pharmacotherapy
200
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
200